AS/Spondyloarthritis

blackboard chalkboard

SpA: Etiology to Diagnosis to Treatment - An Abstract Roundup

Robert Chao
Nov 25, 2020

Here's a review of ten abstracts and presentations on spondyloarthritis encompassing a wide range of topics from etiology to diagnosis to treatment.  

Read Article
#BestACR20Tweets RT @KDAO2011 : FDA updates 6/16/20 canakinumab for AOSD 5/29/20 ixekizumab for nr-AxSpa 80 mg q4wks 3/9/20 nintedanib for progressive ILD 1/29/20 and 6/16/20 secukinumab nr-axSpa 150 mg q4wks, AS 300 mg SQ q4weeks 1/17/20 belimumab label for black pts removed

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020
#BestACR20Tweets "RT @KDAO2011 : Meta-analysis of studies - 4104 pregnancies axSpa/PsA: higher risk for: preterm labor, small for gestational age, C-section No change in miscarriage/stillbirth, gest.diabetes #ACR20, @rheumnow Abstr#1771 https://t.co/xl1YyRPavX

Links:

Dr. John Cush RheumNow ( View Tweet)

Nov 17, 2020
Read Dr.

Links:

Dr. John Cush RheumNow ( View Tweet)
Nov 16, 2020
Our latest article is asking: "Erosions on X-ray: can we delegate this to the computers?" by David Liew ( @drdavidliew) #ACR20 https://t.co/YvKjAWebT9 https://t.co/kIqeX3X0n8

Links:

Dr. John Cush RheumNow ( View Tweet)
Nov 15, 2020
Rheumatology Roundup! We share the highlights of the virtual #ACR20 meeting. https://t.co/WUfpsmuX0g https://t.co/uOScYO9LXr

Links:

Dr. John Cush RheumNow ( View Tweet)
Nov 14, 2020
ACR Mon

ACR20 - Day 4 Report

Jack Cush, MD
Nov 12, 2020

Here are my highlights from day four, Monday, of the ACR 2020 Convergence. 



Vaccine Immunogenicity with Tofacitinib

Read Article
Watch our video with Dr. Petryna ( @DrPetryna) as she discusses inadequate response in spondylitis. #ACR20 https://t.co/TCRoO8qGbs

Links:

Dr. John Cush RheumNow ( View Tweet)

Nov 11, 2020
SI AS SpA ACR

Tofacitinib for Ankylosing Spondylitis

Sheila Marie Reyes
Nov 11, 2020

Investigations on the efficacy and safety of JAK inhibitors as a therapeutic option in the management of AS are increasing. 

Read Article
Roundup RHeum ACR

Rheumatology Round-Up with Drs. Kavanaugh & Cush

Jack Cush, MD
Nov 10, 2020

The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020. Watch now!


Read Article
Watch our video titled Pregnancy in Spondyloarthritis. Dr Richard Conway ( @RichardPAConway) interviews Dr.

Links:

Dr. John Cush RheumNow ( View Tweet)
Nov 10, 2020
Poll results are in! 76% of you take into account the location of bone marrow edema in the SI joint of patients with inflammatory back pain in trying to determine if a patient has SpA! #ACR20 @RheumNow https://t.co/gwySNvfSH5

Links:

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

Nov 10, 2020
Filgo decreased MRI inflammation of many structures early in Rx in SpA which seems novel says w Maksymowych 5M015 @RheumNow #ACR20 @CRASCRRheum #ACRbest https://t.co/LOOOn7Hjvp
Janet Pope Janetbirdope ( View Tweet)
Nov 09, 2020
@rheumnow #ACR20 abs1535 retrospective study of SI MRI reveals 20% pts w/out spondyloarthritis have BME on an MRI, predominantly in the antero-middle quadrant. Erosions were seen in 31% of healthy patients and in 61% of patients with spondyloarthritis

Olga Petryna DrPetryna ( View Tweet)

Nov 09, 2020
Hey Google, does this patient have sacroilitis? Artificial intelligence model validated for detection of radiographic sacroilitis. @RheumNow #ACR20 Abs#2018 https://t.co/TDhGKC8ss4
Robert B Chao, MD doctorRBC ( View Tweet)
Nov 09, 2020
What was the effect of COVID-19 in axSpA patients? From @rheum_cat In the early phase of COVID-19 there was a higher levels of stress and anxiety leading to higher BASDAI scores @RheumNow #ACR20 Abstr#1884

Dr. Antoni Chan synovialjoints ( View Tweet)

Nov 09, 2020
The majority of patients with axSpA were able to use an axSpA smartphone app. recording BASDAI, BASFI 2 weekly. Current disease activity influence adherence to reporting @RheumNow #ACR20 Abstr#1890

Dr. Antoni Chan synovialjoints ( View Tweet)

Nov 09, 2020
COX2 inhibitors associated with inhibition of radiographic spinal progression in AxSpA pts compared to non-selective NSAIDs. ⬇️radiographic spinal progression over 2 yrs ⬇️mSASSS progression @RheumNow #ACR20 Abs#2030 https://t.co/p1CeNBm3ma
Robert B Chao, MD doctorRBC ( View Tweet)
Nov 09, 2020
How do we square up bone loss and new bone formation in AS? Are these coupled? Study from the ASSERT trial showed no relationship between baseline BMD and new syndesmophyte formation in the same vertebra @RheumNow #ACR20 Abstr#1896

Dr. Antoni Chan synovialjoints ( View Tweet)

Nov 09, 2020
Can we find Axial Spa (FaxSpa) using social media? This study used an online screening tool (A-tool) on social media in patients with back pain. 42% had a positive screen and referred for review @RheumNow #ACR20 Abstr#1894

Dr. Antoni Chan synovialjoints ( View Tweet)

Nov 09, 2020
#ACR20 Abs#L11. Efficacy of TOFA vs PBO in AS. At week 16, %ASAS20 responders 56% v 29% PBO; %ASAS40 40% vs 12%. @RheumNow #ACRBest https://t.co/3Faj64rBjd
Eric Dein ejdein1 ( View Tweet)
Nov 09, 2020
Gender disparity in Ankylosing Spondylitis symptoms. 1⃣Women ⬆️Achilles tendonitis, plantar fasciitis, joint swelling, BASDAI>40, DMARD use 2⃣HLA-B not associated w/ enthesitis @RheumNow #ACR20 Abs#1872 https://t.co/bxiNUjY1Xh
Robert B Chao, MD doctorRBC ( View Tweet)
Nov 09, 2020
Study out of China, #ABS1892 shows that patient reported outcomes using self assessments are important in AS T2T and decreasing flare rates #ACR20 @RheumNow. https://t.co/ebGtVUg8IV https://t.co/oXvGxQSjtn

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Nov 09, 2020
Do you routinely request for HLA-B27 in young patients w/ IBP? @RheumNow #ACR20

sheila RHEUMarampa ( View Tweet)

Nov 09, 2020
Do you take into account the location of bone marrow edema in the SI joint of a pt w/ inflammatory back pain when trying to determine if a pt has SpA? Check out Abst1535 at #ACR20 for more thoughts on this. @RheumNow @ElaineHusniMD

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

Nov 09, 2020

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2020 All Rights Reserved.

×